Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa B VanWagner

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
Gastroenterology & Hepatology|May 26, 2021
Best Use of the Transjugular Intrahepatic Portosystemic Shunt Procedure for the Management of Portal HypertensionLisa B VanWagner
Clinical Liver Disease|October 16, 2018
A simple clinical calculator for assessing cardiac event risk in liver transplant candidates: The cardiovascular risk in orthotopic liver transplantation scoreLisa B VanWagner
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 22, 2018
Asprin and statin use for management of atherosclerotic cardiovascular disease in liver transplant candidates: Are we missing the mark?Lisa B VanWagner
Obesity (Silver Spring, Md.)|July 27, 2017
Is Fatty Liver a Risk Marker for Heart Failure?Lisa B VanWagner
Journal of Hepatology|February 8, 2018
New insights into NAFLD and subclinical coronary atherosclerosisLisa B VanWagner
Clinical Liver Disease|December 15, 2020
Introducing <i>Clinical Liver Disease</i> "From Evidence to Practice": Summarizing Systematic Reviews in Hepatology for the Practicing ClinicianLisa B VanWagner
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 17, 2021
Coronary Artery Disease Assessment During Evaluation for Liver Transplantation: How Much Does It Matter?Manhal Izzy, Lisa B VanWagner
World Journal of Hepatology|August 12, 2015
Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic reviewMaureen Whitsett, Lisa B VanWagner
Clinical Liver Disease|August 28, 2018
Clinical Liver Disease: Introducing hot topics in hepatologyLisa B VanWagner, Nancy Reau
Transplantation|November 14, 2022
Preexisting Coronary Artery Disease in Liver Transplant Candidates: Risk Factor or Risk Marker?Lindsay Meurer, Lisa B VanWagner
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
Gastroenterology & Hepatology|May 26, 2021
Best Use of the Transjugular Intrahepatic Portosystemic Shunt Procedure for the Management of Portal HypertensionLisa B VanWagner
Clinical Liver Disease|October 16, 2018
A simple clinical calculator for assessing cardiac event risk in liver transplant candidates: The cardiovascular risk in orthotopic liver transplantation scoreLisa B VanWagner
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 22, 2018
Asprin and statin use for management of atherosclerotic cardiovascular disease in liver transplant candidates: Are we missing the mark?Lisa B VanWagner
Obesity (Silver Spring, Md.)|July 27, 2017
Is Fatty Liver a Risk Marker for Heart Failure?Lisa B VanWagner
Journal of Hepatology|February 8, 2018
New insights into NAFLD and subclinical coronary atherosclerosisLisa B VanWagner
Clinical Liver Disease|December 15, 2020
Introducing <i>Clinical Liver Disease</i> "From Evidence to Practice": Summarizing Systematic Reviews in Hepatology for the Practicing ClinicianLisa B VanWagner
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 17, 2021
Coronary Artery Disease Assessment During Evaluation for Liver Transplantation: How Much Does It Matter?Manhal Izzy, Lisa B VanWagner
World Journal of Hepatology|August 12, 2015
Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic reviewMaureen Whitsett, Lisa B VanWagner
Clinical Liver Disease|August 28, 2018
Clinical Liver Disease: Introducing hot topics in hepatologyLisa B VanWagner, Nancy Reau
Transplantation|November 14, 2022
Preexisting Coronary Artery Disease in Liver Transplant Candidates: Risk Factor or Risk Marker?Lindsay Meurer, Lisa B VanWagner
Pageof 17